Purdue Pharma signs multi-year cloud services deal with Medidata

Purdue signs up for additional cloud services from Medidata.

Purdue Pharma has committed to a multi-year enterprise agreement that will broaden its use of Medidata's cloud-based solutions.

It is hoped that expanding its use of Medidata applications across its portfolio of treatments for pain, sleep and gastrointestinal disorders will allow the firm to improve the operational efficiencies of its clinical trials, while also enabling greater resource savings and more effective decision making.

The pharmaceutical company has used Medidata products across all of its major studies since 2010, including study and protocol design tools and electronic data capture and management systems.

More recently, it adopted the company's clinical trial management system and will now add clinical business analytics to its package.

Charles Willmer, senior director of clinical systems for Purdue, said: "After seeing the results we were able to achieve with Medidata's Clinical Cloud, we have enthusiastically embraced a number of new capabilities."

He added that the expanded agreement with Medidata will enable it to cut the financial and time costs of site negotiation and monitoring, as well as tracking contract resource organisation (CRO) activities more closely.